M. Neri et al., GASTRIC-MUCOSAL INFILTRATION BY HELICOBACTER-PYLORI FAVORS BACTERIAL SURVIVAL AFTER TREATMENT, Alimentary pharmacology & therapeutics, 10(2), 1996, pp. 181-185
Background: Although a number of patient and bacterial factors have be
en identified as predictors of treatment failure in Helicobacter pylor
i-associated gastritis, the causes of lack of response to treatment ha
ve not been fully elucidated. We hypothesized that bacterial infiltrat
ion of the gastric mucosa might be one of the factors responsible for
treatment failure in patients harbouring the bacterium. Methods: We st
udied 182 patients with gastritis who underwent anti-H, pylori treatme
nt with different drugs. Gastric biopsies obtained at endoscopy, were
examined for electron microscopic features of infiltration and damage,
Patients were assigned to different treatment groups, and endoscopy,
evaluation of H. pylori status and electron microscopy were repeated a
t least 4 weeks after the end of treatment, Results: The overall H. py
lori eradication rate was 65%. Eradication was achieved more frequentl
y in patients without electron microscopic features of infiltration (8
5%), than in those patients with the bacteria deeply embedded into the
gastric mucosa (45%; P < 0.0001). No treatment appeared to be clearly
superior for patients with the highest degree of mucosal infiltration
. Conclusions: Bacterial mucosal infiltration may facilitate the survi
val of H. pylori during antibacterial treatment; moreover, electron mi
croscopy may be helpful to identify patients potentially unresponsive
to anti-H. pylori treatment.